AZRX

AzurRx BioPharma (AZRX)

AzurRx BioPharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AZRX
DateTimeSourceHeadlineSymbolCompany
06/08/20217:00AMGlobeNewswire Inc.AzurRx BioPharma CEO James Sapirstein to Present at 2021 BIO Digital NASDAQ:AZRXAzurRx BioPharma Inc
06/07/20217:00AMGlobeNewswire Inc.AzurRx BioPharma Doses First Patient In Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal ... NASDAQ:AZRXAzurRx BioPharma Inc
06/04/20212:00PMGlobeNewswire Inc.UPDATE - FMW Media, Inc.’s “New to The Street” TV Announces 6 Interviews Being Broadcast on NEWSMAX TV, Sunday, June 06... NASDAQ:AZRXAzurRx BioPharma Inc
06/04/20211:02PMGlobeNewswire Inc.FMW Media, Inc.’s “New to The Street” TV Announces 6 Interviews Being Broadcast on NEWSMAX TV, Sunday, June 06, 2021, H... NASDAQ:AZRXAzurRx BioPharma Inc
06/04/20218:29AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) NASDAQ:AZRXAzurRx BioPharma Inc
06/04/20218:25AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) NASDAQ:AZRXAzurRx BioPharma Inc
06/04/20218:21AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) NASDAQ:AZRXAzurRx BioPharma Inc
05/26/20218:37AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3) NASDAQ:AZRXAzurRx BioPharma Inc
05/19/20217:30AMGlobeNewswire Inc.AzurRx BioPharma to Present at Rocky Mountain Microcap Conference (May 26) NASDAQ:AZRXAzurRx BioPharma Inc
05/14/20213:00PMGlobeNewswire Inc.FMW Media, Inc.’s “New to The Street” TV Announces 8 Interviews Being Broadcast on NEWSMAX TV, Sunday, May 16, 2021, Ho... NASDAQ:AZRXAzurRx BioPharma Inc
05/14/20212:45PMGlobeNewswire Inc.FMW Media’s “New To The Street” Syndicated TV Show Features AzurRx BioPharma, Inc. NASDAQ:AZRXAzurRx BioPharma Inc
05/13/20218:07AMSeeking AlphaAzurRx reports clinically meaningful effect in condition linked to cystic fibrosis NASDAQ:AZRXAzurRx BioPharma Inc
05/13/20217:00AMGlobeNewswire Inc.AzurRx BioPharma Announces Positive Interim Data in Phase 2 Clinical Trial of MS1819 in Combination with PERT in the Treatmen... NASDAQ:AZRXAzurRx BioPharma Inc
05/12/20217:30AMGlobeNewswire Inc.AzurRx BioPharma Receives Approximately $550K for its 2020 CIR (French Research Tax Credit) NASDAQ:AZRXAzurRx BioPharma Inc
05/11/20217:30AMGlobeNewswire Inc.AzurRx BioPharma to Present at Investor Summit Group’s Q2 Virtual Investor Summit (May 17) NASDAQ:AZRXAzurRx BioPharma Inc
04/15/20217:30AMGlobeNewswire Inc.AzurRx BioPharma CEO Issues Letter to Shareholders NASDAQ:AZRXAzurRx BioPharma Inc
04/09/20216:04AMEdgar (US Regulatory)Notice of Effectiveness (effect) NASDAQ:AZRXAzurRx BioPharma Inc
04/06/20214:16PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am) NASDAQ:AZRXAzurRx BioPharma Inc
04/06/20217:00AMGlobeNewswire Inc.AzurRx BioPharma Initiates Phase 2 Clinical Trial of Niclosamide for the Treatment of COVID-19 Gastrointestinal Infections NASDAQ:AZRXAzurRx BioPharma Inc
04/01/20218:01AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:AZRXAzurRx BioPharma Inc
03/31/20215:27PMEdgar (US Regulatory)Annual Report (10-k) NASDAQ:AZRXAzurRx BioPharma Inc
03/31/20215:11PMSeeking AlphaAzurRx slides after MS1819 fails in mid-stage cystic fibrosis study NASDAQ:AZRXAzurRx BioPharma Inc
03/31/20214:35PMGlobeNewswire Inc.AzurRx BioPharma Provides Key Takeaways from Phase 2b OPTION 2 Clinical Trial Topline Results Conference Call NASDAQ:AZRXAzurRx BioPharma Inc
03/31/20214:01PMGlobeNewswire Inc.AzurRx BioPharma to Report Topline Data from Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis NASDAQ:AZRXAzurRx BioPharma Inc
03/22/20217:39AMSeeking AlphaAzurRx completes enrollment in mid-stage MS1819 combo cystic fibrosis trial NASDAQ:AZRXAzurRx BioPharma Inc
03/22/20217:00AMGlobeNewswire Inc.AzurRx BioPharma Announces Completion of Enrollment in Phase 2 Clinical Trial of MS1819 in Combination with PERT in the Treat... NASDAQ:AZRXAzurRx BioPharma Inc
03/16/20218:08AMSeeking AlphaAzurRx Bio soars on enrollment completion in study of MS1819 in cystic fibrosis NASDAQ:AZRXAzurRx BioPharma Inc
03/16/20217:00AMGlobeNewswire Inc.AzurRx BioPharma Announces Completion of Enrollment in Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis NASDAQ:AZRXAzurRx BioPharma Inc
03/10/20217:00AMGlobeNewswire Inc.AzurRx BioPharma to Present at the Maxim Group Emerging Growth Virtual Conference (March 17-18) NASDAQ:AZRXAzurRx BioPharma Inc
03/09/20215:29PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) NASDAQ:AZRXAzurRx BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:AZRX
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20210619 20:50:33